De Burlo Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

De Burlo Group Inc

$808 Million
Q3 2024

A detailed history of De Burlo Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, De Burlo Group Inc holds 8,390 shares of REGN stock, worth $5.89 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

8,390

Previous 8,690 3.45%

Holding current value

$5.89 Million

Previous $9.13 Million 3.44%

% of portfolio

1.09%

Previous 1.24%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $307,227 - $360,528	-300 Reduced 3.45%	8,390 $8.82 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $529,920 - $642,714	600 Added 7.42%	8,690 $9.13 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $7.3 Million - $8.04 Million	8,090 New	8,090 $7.79 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $6.06 Million - $7.36 Million	8,900 Added 76.13%	20,590 $16.9 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $6.71 Million - $8.47 Million	11,690 New	11,690 $8.05 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $14.4 Million - $19.4 Million	-26,190 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $8.09 Million - $9.5 Million	13,600 Added 108.02%	26,190 $18.3 Million
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $3.59 Million - $4.44 Million	-6,610 Reduced 34.43%	12,590 $7.95 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $11 Million - $13.1 Million	19,200 New	19,200 $11.6 Million
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $2.27 Million - $2.89 Million	-4,750 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$544.75 - $658.21 $2.59 Million - $3.13 Million	4,750 New	4,750 $2.66 Million
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $5.45 Million - $7.55 Million	-18,200 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $6.77 Million - $8 Million	18,200 New	18,200 $7.47 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Regeneron Pharmaceuticals, Inc. Transaction History